The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
about
Cardiac regulation by phosphoinositide 3-kinases and PTENProtein kinase cascades in the regulation of cardiac hypertrophyMicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologueA comprehensive pathway map of epidermal growth factor receptor signalingThe Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular DiseaseMolecular basis of physiological heart growth: fundamental concepts and new playersPI3Kγ in hypertension: a novel therapeutic target controlling vascular myogenic tone and target organ damageStatus of PI3K/Akt/mTOR pathway inhibitors in lymphomaThe critical role of Akt in cardiovascular functionThe beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophyRole of soluble epoxide hydrolase in postischemic recovery of heart contractile functionAssociation of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytesGas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cellsPPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanismmTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophyHyperglycemia and hyperlipidemia blunts the Insulin-Inpp5f negative feedback loop in the diabetic heartInpp5f is a polyphosphoinositide phosphatase that regulates cardiac hypertrophic responsiveness3'Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium.Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth.Validation of anti-aging drugs by treating age-related diseases.Akt1 in the cardiovascular system: friend or foe?Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo.MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury3,3'Diindolylmethane suppresses vascular smooth muscle cell phenotypic modulation and inhibits neointima formation after carotid injury.Regulation of phosphatase and tensin homolog on chromosome 10 in response to hypoxia.PTEN inhibitors cause a negative inotropic and chronotropic effect in mice.Thyroid hormone inhibits ERK phosphorylation in pressure overload-induced hypertrophied mouse hearts through a receptor-mediated mechanism.Protection of ghrelin postconditioning on hypoxia/reoxygenation in gastric epithelial cellsCardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylationInhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.Ischemic preconditioning inhibits mitochondrial permeability transition pore opening through the PTEN/PDE4 signaling pathwayDeficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunctionModulation of acetylation: creating a pro-survival and anti-inflammatory phenotype in lethal hemorrhagic and septic shock.Thrombin induces NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells by a Rac1-dependent PI3K/Akt pathway.Redox signaling via oxidative inactivation of PTEN modulates pressure-dependent myogenic tone in rat middle cerebral arteriesIschemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathwayPleiotropic effects of glitazones: a double edge sword?Expression of microRNAs is essential for arterial myogenic tone and pressure-induced activation of the PI3-kinase/Akt pathway.Ischemic preconditioning attenuates mitochondrial localization of PTEN induced by ischemia-reperfusion
P2860
Q24317248-91792CBF-8BDA-4B4B-AA01-D9EEE3CDCE05Q24518494-3BFEEBAD-2F5B-4B13-8C00-624CD1886169Q24643939-1D6F203A-AD54-4742-AFBC-1EAC18533DDFQ24672490-F4737555-44A4-4C1B-A67E-FD27ED8B465BQ26774795-398D333B-9351-4213-8516-5EBBDE15E52BQ27006868-32520E9B-D64E-4051-B08F-016CF9BE7F85Q27026365-64463216-CEC1-4C96-AF52-805DD78B0B36Q27026544-836F1BE6-BA56-4941-9B23-F3C146AA6ED3Q28083829-8C1835DF-A245-4CBC-B56E-A2AD2667BD84Q28243220-A40113DE-1B5D-4651-9E29-59771F949CBEQ28397090-BDFDA45A-0799-4260-BB29-1613CA043996Q28566041-AD34C9FC-79EB-4906-9651-49AA26186937Q28576589-56F5D1DB-4913-46CF-B462-491E69F4A5D1Q28578260-FE97D53D-1F35-4EA7-8977-CFBBB31E97F8Q28580875-30262814-BBEF-4D31-AB1C-D3D1C88D2DBCQ28583384-E5A4194F-BDB4-472B-9ED5-D06F7CD64A86Q28583594-C33B5AA9-8D5E-4CFA-9D35-7F0519EC441FQ28590549-93ED8F2B-BC5C-49B7-A16C-0C9B82BC59B7Q33262306-2B669E32-D6C7-4849-9C01-CDB8434F1F7BQ33277534-E59F279C-0784-4EEB-9974-4DF04E268A04Q33588700-B415C283-F2A5-4A22-8677-B6A625F69592Q33905832-5252B1FC-7386-4451-841C-14D2AC3EA62DQ34078704-48D94ABC-20C5-4D19-9A26-9447198701D9Q34207303-CF5118C4-7854-4D81-A956-120FB88A4C79Q34233778-6A86027F-A9C9-43FA-9C36-562E7070A135Q34257074-BF877FF9-E88B-49CE-B318-2FDF281B933DQ34384591-A36B1FE2-A8A1-45EA-B693-09F83B96BFC6Q34426441-C223E53B-B6B7-4225-AD32-8A13668C2E3EQ34451810-65BFAEDD-00D9-414C-AEBD-D191627E3EEEQ34479210-52EF6374-4F01-4AF4-89C4-8399A61BFFE1Q34494032-F58E2935-33F4-4FB4-8486-1DD08495CF6BQ34558225-083E945B-AE57-494B-834E-56B618535C29Q34629075-B0EBBAF0-1E78-4BB3-8C27-D17267EC9801Q34635234-6F1CF696-65EE-4DB9-B344-28E4C028EB52Q34695835-5FC3D306-34FE-4459-B7D0-9A1F880E436DQ34827639-69B5CDA9-422B-4072-9FF1-24F59912E46EQ35009164-E1506FFB-9999-4397-BC80-1113B8D62EDBQ35025858-1523D2F4-AED7-4D52-AACB-094A21E6ACC3Q35043317-E647BEDC-3E85-42BC-B104-D3F298AA2093Q35056941-E1834E6F-F692-4FE5-8451-EE4833DD74B5
P2860
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
@ast
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
@en
type
label
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
@ast
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
@en
prefLabel
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
@ast
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
@en
P2093
P1476
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.
@en
P2093
Benoit-Gilles Kerfant
Gavin Y Oudit
Michael A Crackower
Peter H Backx
P304
P356
10.1016/J.YJMCC.2004.05.015
P577
2004-08-01T00:00:00Z